- Home
- NPKI vs ORIC Comparison
NPKI vs ORIC Comparison
Compare NPKI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPKI
- ORIC
- Stock Information
- Founded
- NPKI 1932
- ORIC 2014
- Country
- NPKI United States
- ORIC United States
- Employees
- NPKI N/A
- ORIC N/A
- Industry
- NPKI Metal Fabrications
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- NPKI Industrials
- ORIC Health Care
- Exchange
- NPKI Nasdaq
- ORIC Nasdaq
- Market Cap
- NPKI 621.1M
- ORIC 735.3M
- IPO Year
- NPKI N/A
- ORIC 2020
- Fundamental
- Price
- NPKI $6.85
- ORIC $10.84
- Analyst Decision
- NPKI
- ORIC Strong Buy
- Analyst Count
- NPKI 0
- ORIC 9
- Target Price
- NPKI N/A
- ORIC $18.75
- AVG Volume (30 Days)
- NPKI 385.2K
- ORIC 825.1K
- Earning Date
- NPKI 02-19-2025
- ORIC 03-10-2025
- Dividend Yield
- NPKI N/A
- ORIC N/A
- EPS Growth
- NPKI N/A
- ORIC N/A
- EPS
- NPKI N/A
- ORIC N/A
- Revenue
- NPKI $748,372,000.00
- ORIC N/A
- Revenue This Year
- NPKI N/A
- ORIC N/A
- Revenue Next Year
- NPKI N/A
- ORIC N/A
- P/E Ratio
- NPKI N/A
- ORIC N/A
- Revenue Growth
- NPKI 93.70
- ORIC N/A
- 52 Week Low
- NPKI $5.61
- ORIC $6.33
- 52 Week High
- NPKI $8.65
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- NPKI N/A
- ORIC 52.90
- Support Level
- NPKI N/A
- ORIC $9.92
- Resistance Level
- NPKI N/A
- ORIC $12.00
- Average True Range (ATR)
- NPKI 0.00
- ORIC 0.90
- MACD
- NPKI 0.00
- ORIC 0.04
- Stochastic Oscillator
- NPKI 0.00
- ORIC 41.82
About NPKI NPK International Inc. Common Stock
NPK International Inc Formerly Newpark Resources Inc is a diversified supplier providing environmentally-sensitive products, as well as rentals and services to customers across multiple industries. The company has two operating segments: Industrial Solutions and Fluids Systems. Fluids Systems segment which generates the majority of the revenue, provides drilling, completion, and stimulation fluids products and related technical services to customers for oil, natural gas, and geothermal projects. Geographically, the company derives majority of its revenue from the United States and also has its presence in Canada, EMEA, Latin America, and Asia Pacific regions.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.